State of Alaska Department of Revenue lessened its position in shares of USANA Health Sciences, Inc. (NYSE:USNA – Get Rating) by 11.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,709 shares of the company’s stock after selling 1,000 shares during the period. State of Alaska Department of Revenue’s holdings in USANA Health Sciences were worth $432,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. National Bank of Canada FI grew its holdings in USANA Health Sciences by 1.5% during the 2nd quarter. National Bank of Canada FI now owns 13,571 shares of the company’s stock worth $981,000 after acquiring an additional 206 shares in the last quarter. Mutual of America Capital Management LLC lifted its position in shares of USANA Health Sciences by 14.9% during the 2nd quarter. Mutual of America Capital Management LLC now owns 1,934 shares of the company’s stock worth $140,000 after buying an additional 251 shares during the last quarter. Rhumbline Advisers lifted its position in shares of USANA Health Sciences by 1.2% during the 2nd quarter. Rhumbline Advisers now owns 31,544 shares of the company’s stock worth $2,283,000 after buying an additional 362 shares during the last quarter. Covestor Ltd lifted its position in shares of USANA Health Sciences by 92.7% during the 1st quarter. Covestor Ltd now owns 927 shares of the company’s stock worth $74,000 after buying an additional 446 shares during the last quarter. Finally, Guggenheim Capital LLC lifted its position in shares of USANA Health Sciences by 6.2% during the 1st quarter. Guggenheim Capital LLC now owns 9,257 shares of the company’s stock worth $736,000 after buying an additional 538 shares during the last quarter. Institutional investors and hedge funds own 52.62% of the company’s stock.
USANA Health Sciences Price Performance
USNA stock opened at $57.83 on Friday. The company has a fifty day moving average price of $53.58 and a 200 day moving average price of $60.19. USANA Health Sciences, Inc. has a 12 month low of $48.61 and a 12 month high of $101.53. The company has a market cap of $1.11 billion, a price-to-earnings ratio of 14.60 and a beta of 0.71.
Insiders Place Their Bets
In other USANA Health Sciences news, insider Daniel A. Macuga sold 1,474 shares of the company’s stock in a transaction on Monday, December 5th. The shares were sold at an average price of $53.92, for a total transaction of $79,478.08. Following the completion of the transaction, the insider now owns 2,234 shares in the company, valued at approximately $120,457.28. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.36% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on the stock. StockNews.com assumed coverage on shares of USANA Health Sciences in a research report on Wednesday, October 12th. They set a “buy” rating for the company. DA Davidson reduced their price objective on shares of USANA Health Sciences from $57.00 to $49.00 and set a “neutral” rating for the company in a research report on Thursday, October 27th.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products.
- Get a free copy of the StockNews.com research report on USANA Health Sciences (USNA)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here’s Why
- Carvana Stock Rally, Here’s What You Need to Know
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.